Trials / Sponsors / China Immunotech (Beijing) Biotechnology Co., Ltd.
China Immunotech (Beijing) Biotechnology Co., Ltd.
Industry · 9 registered clinical trials — 8 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia Autoimmune Hemolytic Anemia | Phase 1 | 2026-03-18 |
| Recruiting | An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus, Lupus Nephritis (LN), Sjogren's Syndrome | Phase 1 | 2025-11-24 |
| Recruiting | Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Sjogren's Syndrome (SS) | Phase 1 | 2025-11-13 |
| Recruiting | A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS) | Phase 1 | 2025-08-13 |
| Recruiting | A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Systemic Sclerosis (SSc) | Phase 1 | 2025-08-04 |
| Recruiting | A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy | Phase 1 | 2025-05-19 |
| Recruiting | A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus Lupus Nephritis (LN), Immune Thrombocytopenia (ITP) | Phase 1 | 2025-04-16 |
| Completed | A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia Autoimmune Hemolytic Anemia | Phase 1 | 2025-01-15 |
| Recruiting | An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease Systemic Lupus Erythematosus, Systemic Sclerosis, Inflammatory Myopathy | N/A | 2024-04-24 |